PwC forecasts that M&A activity in the healthcare sector will be particularly dynamic this year, driven by the increasing demand for high-quality medical services and the rising middle class.
Private hospitals and specialised healthcare facilities, particularly in ophthalmology and oncology, are expected to be key targets for M&A transactions.
The report highlights that global M&A activity in the healthcare sector is being fuelled by product shortages, supply chain risks and new regulatory policies.
In the pharmaceutical and life sciences industries, M&A deals are focused on biotechnology as companies seek to address the expiration of patent exclusivity and divest non-core assets to optimise their investment portfolios.
Private equity funds are also showing a growing interest in medical technology and digital health. This creates attractive divestment opportunities for companies backed by private equity investors.
Retail healthcare businesses and over-the-counter drug retailers, which are restructuring into independent legal entities or divesting assets, are also actively engaging in M&A to rapidly transform their business models.
Partner and Transaction Services Leader at PwC Vietnam Ong Tiong Hooi emphasised that global M&A activity is on a strong recovery trajectory in 2025, driven by improving economic conditions and strategic acquisitions.
This trend is also reflected in Vietnam, where M&A transactions are increasing across various sectors.
He said that domestic enterprises are taking a leading role in high-value deals. Meanwhile, foreign investors are returning to the market, with a focus on the promising healthcare and education sectors.
Globally, M&A in the education sector is witnessing significant growth, with private equity funds accounting for 50-70% of total investments.
Vietnam’s education sector is seen as increasingly attractive for M&A, thanks to strong incentives for foreign investment and no restrictions on investment capital in educational institutions./
